Biologics and immunotherapies are revolutionizing the landscape of modern medicine by leveraging the body’s natural defense mechanisms and biological molecules to prevent, manage, and cure diseases. Unlike conventional small molecule drugs, biologics are typically large, complex molecules such as monoclonal antibodies, recombinant proteins, nucleic acids, and cell based therapies. Immunotherapy, a rapidly expanding subset of biologics, harnesses and modulates the immune system to fight cancers, autoimmune diseases, and infectious conditions with unprecedented precision and durability.

The Journal of Pharmaceutical Sciences and Drug Research (JPSD) highlights Emerging Trends in Biologics and Immunotherapy as a transformative field that continues to reshape pharmaceutical sciences and clinical practice. The convergence of biotechnology, immunology, genomics, and advanced delivery technologies is enabling novel therapies that once seemed impossible, making this domain one of the most dynamic areas of drug research and development.